Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Evaluation of Safety and Efficacy of Anecortave Acetate Versus Placebo in Patients With Subfoveal Choroidal Neovascularization Due to Exudative Age-Related Macular Degeneration.

NCT00051129 is registered in ClinicalTrials.gov with Alcon Research as lead sponsor.

NCT NCT00051129
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00051129 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Evaluation of Safety and Efficacy of Anecortave Acetate Versus Placebo in Patients With Subfoveal Choroidal Neovascularization Due to Exudative Age-Related Macular Degeneration.
Lead sponsor
Alcon Research
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2007
Completion date
May 31, 2008
Enrollment
291 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

age-related maculopathies, age-related maculopathy, macular degeneration, maculopathies, age-related, maculopathy, age-related